Table 4.
Estimates of liver fibrosis using biochemical markers and transient elastography, mean (range)
| HIV (n = 71) | HCV (n = 53) | HIV/HCV (n = 57) | |
| APRI | 0.31 (0.1-1.6)ab | 0.93 (0.28-6.07) | 0.92 (0.17-19.7) |
| FIB-4 | 0.93 (0.39-4.28)a | 1.62 (0.47-12.6) | 1.63 (0.63-23.8) |
| LS | 5.4 (3.2-26.6)ab | 7.3 (3.4-40.9)c | 9.8 (4.3-48.8) |
a
P < 0.0001 vs hepatitis C virus (HCV);
b
P < 0.0001,
c
P < 0.05 vs human immunodeficiency virus (HIV)/HCV. LS: Liver stiffness; APRI: Aspartate aminotransferase platelet ratio index.